Bert Vander Cruyssen

Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery

Bert Vander Cruyssen, Elisa Muñoz-Gomáriz, Pilar Font et al. · Lara D. Veeken · 2009 · 210 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +14

Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification

Gust Verbruggen, Ruth Wittoek, Bert Vander Cruyssen et al. · Annals of the Rheumatic Diseases · 2011 · 199 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Predicting the outcome of ankylosing spondylitis therapy

Nathan Vastesaeger, Désirée van der Heijde, Robert D. Inman et al. · Annals of the Rheumatic Diseases · 2011 · 190 citations · Full text

Medicine, Pharmacotherapy, Clinical Epidemiology +15

Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial

M. Kloppenburg, Roberta Ramonda, Klaus Bobacz et al. · Annals of the Rheumatic Diseases · 2018 · 164 citations

Medicine, Pharmacology, Pharmacotherapy +14

Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis

Martine De Vos, Olivier Dewit, Geert D’Haens et al. · Journal of Crohn s and Colitis · 2011 · 140 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14